Rescue of Adult Neurogenesis in Down Syndrome Mouse Model [PDF]
poster abstractDown Syndrome (DS) is a disease caused by the complete or partial trisomy of human chromosome 21, which can cause abnormal development, structure, and function of neural networks in the brain.
East, Josh
core
New 5-ylidene rhodanine derivatives based on the dispacamide A model.
International audienceA practical approach for the preparation of ([Formula: see text]) 5-ylidene rhodanine derivatives bearing the (4,5-dihalogeno-pyrrol-2-yl)carbamoyl fragment of dispacamide A is reported.
Bazureau, Jean-Pierre +6 more
core +4 more sources
Inestabilidad genómica inducida por la activación sostenida de la vía de señalización WNT/β-catenina en células progenitoras neuronales humanas [PDF]
Tesis (Ingeniero en Biotecnología)proyecto Fondecyt N°1180848El Trastorno del Espectro Autista (TEA) es un grupo de trastornos del neurodesarrollo, que incluye un lenguaje retrasado o anormal, déficits en la interacción social y conductas e intereses ...
Fuente Villaseca, Nicolás Andrés de la
core
Can Epigallocatechin gallate (EGCG) Treatment Rescue Hippocampal-Dependent Cognitive Function in a Down Syndrome Mouse Model? [PDF]
poster abstractDown Syndrome (DS) is caused by the trisomy of human chromosome 21 (Hsa21). Trisomy 21 can cause various behavioral, cognitive, learning and memory deficits.
Abeysekera, Irushi +4 more
core
RNF169 and RNF168 novel substrates of DYRK1A : connecting DYRK1A to DNA-damage repair
Programa de doctorat en ...
openaire +1 more source
Diabetic foot ulcer (DFU), a serious complication of diabetes, remains a clinical challenge. MicroRNAs affect inflammation and may have therapeutic value in DFU.
Keyan Hu +9 more
doaj +1 more source
Editorial: Advances in DYRK1A syndrome: underlying mechanisms, disease models, and novel therapeutic approaches. [PDF]
Glass OK, Piton A, Pfalzer A.
europepmc +1 more source
Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A. [PDF]
Chen J +11 more
europepmc +1 more source
Neuroprotective therapy after traumatic brain injury: does the window for treatment extend for months? [PDF]
Lynch C, Diaz-Arrastia R.
europepmc +1 more source

